260 related articles for article (PubMed ID: 16473124)
1. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.
Hoelscher MA; Garg S; Bangari DS; Belser JA; Lu X; Stephenson I; Bright RA; Katz JM; Mittal SK; Sambhara S
Lancet; 2006 Feb; 367(9509):475-81. PubMed ID: 16473124
[TBL] [Abstract][Full Text] [Related]
2. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
3. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
4. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
Mayrhofer J; Coulibaly S; Hessel A; Holzer GW; Schwendinger M; Brühl P; Gerencer M; Crowe BA; Shuo S; Hong W; Tan YJ; Dietrich B; Sabarth N; Savidis-Dacho H; Kistner O; Barrett PN; Falkner FG
J Virol; 2009 May; 83(10):5192-203. PubMed ID: 19279103
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
[TBL] [Abstract][Full Text] [Related]
6. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
8. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
9. Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
Cheng T; Wang X; Song Y; Tang X; Zhang C; Zhang H; Jin X; Zhou D
Vaccine; 2016 Sep; 34(41):4875-4883. PubMed ID: 27576071
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
11. Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
Yang P; Duan Y; Zhang P; Li Z; Wang C; Dong M; Tang C; Xing L; Gu H; Zhao Z; Liu X; Zhang S; Wang X
PLoS One; 2012; 7(1):e30252. PubMed ID: 22279575
[TBL] [Abstract][Full Text] [Related]
12. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
13. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.
Tumpey TM; Renshaw M; Clements JD; Katz JM
J Virol; 2001 Jun; 75(11):5141-50. PubMed ID: 11333895
[TBL] [Abstract][Full Text] [Related]
14. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
15. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
[TBL] [Abstract][Full Text] [Related]
16. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
[TBL] [Abstract][Full Text] [Related]
17. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
[TBL] [Abstract][Full Text] [Related]
18. New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.
Hoelscher MA; Jayashankar L; Garg S; Veguilla V; Lu X; Singh N; Katz JM; Mittal SK; Sambhara S
Clin Pharmacol Ther; 2007 Dec; 82(6):665-71. PubMed ID: 17957181
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
[TBL] [Abstract][Full Text] [Related]
20. New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.
Steel J
BioDrugs; 2011 Oct; 25(5):285-98. PubMed ID: 21942913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
